Skip to main content

Alert!

There has been an error in displaying this message. Please contact the site administrator.

News & Articles

UTHealth Houston Research

April 20, 2026
Written By: Jeannette Sanchez | Updated: April 20, 2026
CrossBridge Bio, a biotechnology company developing next-generation antibody-drug conjugates based on discoveries by researchers at UTHealth Houston, is taking a major step toward clinical translation after being acquired by Eli Lilly.
The risk of Alzheimer’s disease significantly decreases in older adults who receive a higher dose of the influenza vaccine compared to the standard dose, according to new research led by UTHealth Houston. 
Multiple regions of the brain engage in fast-moving conversations to understand language, UTHealth Houston researchers have discovered, dispelling a prior school of thought that only one region of the brain was responsible for language processing.
April 10, 2026
Written By: Sydney Lowther | Updated: April 10, 2026
Daily consumption of more than nine servings of ultraprocessed foods increased the risk of suffering from a major cardiac event by 67%, according to new research led by UTHealth Houston.
Six months after receiving a groundbreaking, experimental new surgery for spina bifida at UTHealth Houston, Nova continues to flourish. 
March 11, 2026
Written By: Laura Frnka-Davis | Updated: March 11, 2026
A study by researchers at UTHealth Houston concluded that fetoscopic ablation is an alternative treatment for select cases of vasa previa. The findings were published in Ultrasound in Obstetrics & Gynecology. 
March 11, 2026
Written By: Kenny Bybee | Updated: March 11, 2026
UTHealth Houston again ranks among the nation’s leading institutions for National Institutes of Health research funding, according to the latest annual analysis by the Blue Ridge Institute for Medical Research.
Seven years after being diagnosed with Leigh syndrome, Asher Times is defying the odds — walking, talking, eating, and attending school in a mainstream classroom — thanks to the specialized care he’s received from Mary Kay Koenig, MD, director of the Center for the Treatment of Pediatric Neurologic and Neurodegenerative Disease at McGovern Medical School at UTHealth Houston.
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a promising avenue to treat cancer, according to new research by UTHealth Houston.
January 15, 2026
Written By: Laura Frnka-Davis | Updated: January 15, 2026
Researchers at UTHealth Houston have been awarded three grants totaling more than $5 million from the National Institutes of Health and the National Science Foundation (NSF) to address one of the biggest challenges in modern health care: building enhanced data resources and technologies to accelerate scientific discovery and improve decision-making in medicine.